Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Genitourinary Cancers
•
Prostate Cancer
•
Medical Oncology
•
Primary Care
How can we symptomatically manage dizziness or risk of fall in older patients on enzalutamide ?
Related Questions
Would you prescribe semaglutide for weight gain from androgen deprivation therapy for prostate cancer?
Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?
How would you approach patients with high-risk localized prostate cancer (per STAMPEDE criteria) receiving RT and concurrent ADT but are unable to tolerate abiraterone secondary to toxicities?
How do you manage prostate cancer in patients that cannot swallow pills?
For a patient post-prostatectomy with a high PSA (>1), a negative MRI pelvis, and a negative PSMA PET scan, do you pursue any other imaging?
How do you reconcile discordant PSMA and MRI findings in patients undergoing definitive radiotherapy for prostate cancer?
What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?
Do you offer RT both to the prostate and synchronous oligometastases in de novo oligometastatic prostate cancer?
What are your top takeaways in GU Cancers from ESMO 2024?
How would you sequence PARPi vs pembrolizumab for a patient who has progressed on ARPI to mCRPC that has somatic PALB2 mutation and MSI-H?
